Robert Wieder, MD, PhD
Dr. Wieder is Provost of Rutgers Biomedical and Health Sciences–Newark, Professor of Medicine and Associate Director for Clinical and Translational Research at the Rutgers New Jersey Medical School Cancer Center. As a University of Pennsylvania undergraduate, he majored in biochemistry and biology. He earned his MD and PhD (biophysics of DNA renaturation) from Mount Sinai School of Medicine. He did a residency in internal medicine at Montefiore Hospital of the Albert Einstein College of Medicine and at the National Heart, Lung and Blood Institute (NHLBI). While at NHLBI, he also completed a fellowship in gene therapy. He subsequently did a fellowship in Medical Hematology/Oncology at Memorial Sloan-Kettering Cancer Center, where he worked on cell signaling in malignant transformation. After a year as part of the Autologous Bone Marrow Transplant Service, Dr. Wieder came to the New Jersey Medical School (NJMS), where he has studied breast cancer re-differentiation in the bone marrow and mechanisms of dormancy and chemoresistance, with funding provided by the Department of Defense and the National Institutes of Health. His research also addresses cancer treatment outcomes in minority populations.
In his role as a medical oncologist, Dr. Wieder developed the NJMS Cancer Center's clinical research program and received NCI designation as a Minority-Based Clinical Community Oncology Program (MB-CCOP). Dr. Wieder chaired the New Jersey Cancer Commission Breast Cancer Advisory Board for seven years and served on the NCI Breast Cancer Steering Committee. He also has an extensive service and teaching record at NJMS.